MedTrace Logo

Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies

NCT00470743 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2015-09-02

No results posted yet for this study

Summary

The purpose of the study is to determine the safety and efficacy of ibuprofen, compared with indomethacin, in the treatment for the closure of the patent ductus arteriosus in premature babies born under 29 weeks gestation

Conditions

  • Ductus Arteriosus, Patent
  • Very Low Birth Weight Infants

Interventions

DRUG

Ibuprofen

DRUG

Indomethacin

Sponsors & Collaborators

  • National University Hospital, Singapore

    collaborator OTHER

  • Cumberland Pharmaceuticals

    collaborator INDUSTRY

  • KK Women's and Children's Hospital

    lead OTHER_GOV

Principal Investigators

  • Quek Bin Huey, MMed MRCP · KK Women's and Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
29 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00470743 on ClinicalTrials.gov